OtherINTERVENTIONAL
Intraarterially Administered Abciximab as an Adjuvant Thrombolytic Therapy: Report of Three Cases
O-Ki Kwon, Ki Jae Lee, Moon Hee Han, Chang-Wan Oh, Dae Hee Han and Young Cho Koh
American Journal of Neuroradiology March 2002, 23 (3) 447-451;
O-Ki Kwon
Ki Jae Lee
Moon Hee Han
Chang-Wan Oh
Dae Hee Han
References
- ↵EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956–961
- ↵Lempert TE, Malek AM, Halbach VV, Phatouros CC, Dowd CF, Higashida RT. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during coil embolization. Stroke 1999;30:693–695
- ↵Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601–609
- ↵Wallace RC, Furlan AJ, Moliterno DJ, Stevens GH, Masaryk TJ, Perl J II. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol 1997;18:1257–1260
- ↵Merlini PA, Bauer KA, Oltrona L, et al. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1995;25:203–209
- ↵Coller BS. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 1997;78:730–755
- ↵Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis.” J Clin Invest 1996;98:863–874
- ↵Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982;122:429–436
- ↵Osterud B, Rapaport SI, Lavine KK. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood 1977;49:819–834
- ↵Hultin MB. The modulation of thrombin activation of factor VIII by calcium ions, phospholipids and platelets. Blood 1985;66:53–58
- ↵Walsh PN, Schmaier AH. Platelet-coagulant protein interactions. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, Pa: J.B. Lippincott Co;1994;629–651
- ↵Reed GL, Matsueda GR, Haber E. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin. Thromb Haemost 1992;68:315–320
- ↵Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsch J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385–391
- ↵Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980;65:64–73
- ↵Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 1997;99:1467–1471
- ↵Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 Trial. Circulation. 1999;99:2720–2732
- ↵Mascelli MA, Lance ET, Damajaru L, Wagner CL, Weisman HF, Jordan RE. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual ecovery from GP IIb/IIIa receptor blockade. Circulation 1998;97:1680–1688
- ↵Theron J, Courtheoux P, Casasco A, et al. Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol 1989;10:753–765
In this issue
Advertisement
Intraarterially Administered Abciximab as an Adjuvant Thrombolytic Therapy: Report of Three Cases
O-Ki Kwon, Ki Jae Lee, Moon Hee Han, Chang-Wan Oh, Dae Hee Han, Young Cho Koh
American Journal of Neuroradiology Mar 2002, 23 (3) 447-451;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis
- Emergency reconstructive endovascular management of intraoperative complications involving the internal carotid artery from trans-sphenoidal surgery
- Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms
- Abciximab Is a Safe Rescue Therapy in Thromboembolic Events Complicating Cerebral Aneurysm Coil Embolization: Single Center Experience in 42 Cases and Review of the Literature
- Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association
- Local Intra-arterial Fibrinolysis of Thromboemboli Occurring During Neuroendovascular Procedures With Recombinant Tissue Plasminogen Activator
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement